InfuSystem Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Revenue (Tables)

3 Months Ended

Mar. 31, 2024

The following table presents the Company’s disaggregated revenue by offering type (in thousands):


	Three Months Ended March 31,
	2024				2023
	Total Net Revenues		Percentage of Total Net Revenues		Total Net Revenues		Percentage of Total Net Revenues
Patient Services revenue recognized at a point in time:
Direct products	$	615	1.9	%	$	579	1.9	%
Third-Party Payer products	1,872		5.9	%	3,408		11.2	%
Patient Services revenue recognized over time:
Direct rental services	3,572		11.2	%	1,869		6.2	%
Third-Party Payer rental services	10,977		34.3	%	11,020		36.3	%
Total Patient Services accounted for under ASC 606	17,036		53.2	%	16,876		55.6	%
Device Solutions revenue recognized at a point in time:
Products	4,213		13.2	%	3,740		12.3	%
Services	2,409		7.5	%	2,576		8.5	%
Device Solutions revenue recognized over time:
Services	1,969		6.2	%	774		2.5	%
Total Device Solutions accounted for under ASC 606	8,591		26.9	%	7,090		23.3	%
Total Revenue Accounted for under ASC 606	25,627		80.1	%	23,966		78.9	%
Patient Services lease revenue	1,555		4.9	%	1,897		6.2	%
Device Solutions lease revenue	4,813		15.0	%	4,507		14.8	%
Total Revenue accounted for under ASC 842, Leases	6,368		19.9	%	6,404		21.1	%
Total Net Revenue	$	31,995	100.0	%	$	30,370	100.0	%